HAEMONETICS CORP - Common stock, $0.01 par value per share (HAE)

CUSIP: 405024100

Q1 2019 13F Holders as of 31 Mar 2019

Holder snapshot 7 signals
Share change
+858,817
Put/Call ratio
28%
SEC-reported price per share
$87.48
Indexed holders
253
Value change
+$62,307,595
Number of buys
125
Open additional details 1 more signal available
Number of sells
149
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
45,420,621

Security key

405024100

Report period

Q1 2019

Indexed institutions

253

Top holders

10

Ownership snapshot

Top reported holders of HAE - HAEMONETICS CORP - Common stock, $0.01 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
BlackRock Finance, Inc.
Disclosed value leader
BlackRock Finance, Inc.
Comparable rows
0/15
Latest evidence
31 Dec 2018
13F Highest disclosed value: $602,982,000 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

BlackRock Finance, Inc. has the largest disclosed position value at $602.98M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens BlackRock Finance, Inc.'s linked filing trail.
Disclosed position value Top 5
BlackRock Finance, Inc. $602.98M
VANGUARD GROUP INC $562.28M
WELLINGTON MANAGEMENT GROUP LLP $495.02M
RENAISSANCE TECHNOLOGIES LLC $242.08M
STATE STREET CORP $165.99M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
BlackRock Finance, Inc.
13F
Company
13F
—
denominator unverified
$602,982,000
6,026,806 shares
— 31 Dec 2018
VANGUARD GROUP INC
13F
Company
13F
—
denominator unverified
$562,281,000
5,619,997 shares
— 31 Dec 2018
WELLINGTON MANAGEMENT GROUP LLP
13F
Company
13F
—
denominator unverified
$495,020,000
4,947,734 shares
— 31 Dec 2018
RENAISSANCE TECHNOLOGIES LLC
13F
Company
13F
—
denominator unverified
$242,081,000
2,419,600 shares
— 31 Dec 2018
STATE STREET CORP
13F
Company
13F
—
denominator unverified
$165,989,000
1,659,058 shares
— 31 Dec 2018
Jackson Square Partners, LLC
13F
Company
13F
—
denominator unverified
$146,845,000
1,467,726 shares
— 31 Dec 2018
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2019

Investor-level positions for this CUSIP, loaded as an interactive table.

Indexed institutions
253
Shares
51,283,498
Indexed holders
253
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Reported share positions only; options and principal amounts are excluded. Missing manager disclosures are unavailable, not zero. A missing position becomes zero only when complete coverage is verified for both snapshots. Counts describe the indexed universe; the comparison may cover a smaller set.

Compare Q1 2019 vs Q4 2018 Across Filers

Q4 2018 indexed holders
277
Q1 2019 indexed holders
253
Indexed holder difference
-24
Investor Q4 2018 Shares Q1 2019 Shares Share Diff Share Chg % Q4 2018 value Q1 2019 value Value change Value Chg %

Trend: the last eight indexed quarters, including the selected comparison periods.

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .